Market revenue in 2023 | USD 76.7 million |
Market revenue in 2030 | USD 233.8 million |
Growth rate | 17.3% (CAGR from 2023 to 2030) |
Largest segment | Regenerative medicine |
Fastest growing segment | Drug Discovery & Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regenerative Medicine, Drug Discovery & Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.35% in 2023. Horizon Databook has segmented the China human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Companies such as HeZe biotechnology Co. Ltd., Union East China Stem Cell Gene Engineering Co. Ltd., and Union Stem Cell Genetic Co. Ltd hold important patents associated with stem cells. These companies are anticipated to propel growth to substantial extent in the Chinese hESC market.
Presence of research funding programs for hESC and iPS as well as the availability of fundamental facilities in research laboratories in Shanghai and Beijing is expected to enhance market progress. In addition to this, China is projected to grasp the advances in regenerative medicine with respect to its international collaborations for stem cell research.
The Ministry of Science and Technology has established 4 stem cell banks in the country covering east, south, and north of China. These banks are expected to provide about 4 key technology platforms by supporting each other.
Horizon Databook provides a detailed overview of country-level data and insights on the China human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into China human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account